-
2008
Company Description
Nanodex, an R&D venture company, provides the synthesis and application of folate-modified cyclodextrins as artificial cancer antibodies.
Nanodex is an R&D venture company that provides the synthesis and application of folate-modified cyclodextrins as artificial cancer antibodies. It is based in Tokyo, Japan.
-
Manufacturer:
Data and Analytics -
Formed:
2008 -
Company Website:
-
Company E-mail:
-
Company Address:
JapanTokyo -
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits